Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Psychometric properties of sleep and coping numeric rating scales in rheumatoid arthritis: a subanalysis of an etanercept trial.

Avila-Ribeiro P, Brault Y, Dougados M, Gossec L.

Clin Exp Rheumatol. 2017 Sep-Oct;35(5):786-790. Epub 2017 Mar 23.

PMID:
28339355
2.

Identifying patients with rheumatoid arthritis with moderate disease activity at risk of significant radiographic progression despite methotrexate treatment.

Fautrel B, Nab HW, Brault Y, Gallo G.

RMD Open. 2015 Jul 28;1(1):e000018. doi: 10.1136/rmdopen-2014-000018. eCollection 2015.

3.

When to adjust therapy in patients with rheumatoid arthritis after initiation of etanercept plus methotrexate or methotrexate alone: findings from a randomized study (COMET).

Dougados MR, van der Heijde DM, Brault Y, Koenig AS, Logeart IS.

J Rheumatol. 2014 Oct;41(10):1922-34. doi: 10.3899/jrheum.131238. Epub 2014 Aug 15.

PMID:
25128520
4.

Retreatment in patients with psoriasis achieving response with etanercept after relapse due to treatment interruption: results from the CRYSTEL study.

Griffiths CE, Luger TA, Brault Y, Germain JM, Mallbris L.

J Eur Acad Dermatol Venereol. 2015 Mar;29(3):468-73. doi: 10.1111/jdv.12585. Epub 2014 Aug 4.

PMID:
25087839
5.

Etanercept reduces symptoms and severity of psoriasis after cessation of cyclosporine therapy: results of the SCORE study.

Micali G, Wilsmann-Theis D, Mallbris L, Gallo G, Marino V, Brault Y, Germain JM.

Acta Derm Venereol. 2015 Jan;95(1):57-61. doi: 10.2340/00015555-1845.

6.

Clinical and ultrasound-based composite disease activity indices in rheumatoid arthritis: results from a multicenter, randomized study.

Mandl P, Balint PV, Brault Y, Backhaus M, D'Agostino MA, Grassi W, van der Heijde D, de Miguel E, Wakefield RJ, Logeart I, Dougados M.

Arthritis Care Res (Hoboken). 2013 Jun;65(6):879-87. doi: 10.1002/acr.21913.

7.

A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis.

Ortonne JP, Paul C, Berardesca E, Marino V, Gallo G, Brault Y, Germain JM.

Br J Dermatol. 2013 May;168(5):1080-7. doi: 10.1111/bjd.12060.

PMID:
23013207
8.

Comparison of patient satisfaction with two different etanercept delivery systems. A randomised controlled study in patients with rheumatoid arthritis.

Müller-Ladner U, Flipo RM, Vincendon P, Brault Y, Kielar D.

Z Rheumatol. 2012 Dec;71(10):890-9. doi: 10.1007/s00393-012-1034-4.

PMID:
22956167
9.

Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID).

Dougados M, Brault Y, Logeart I, van der Heijde D, Gossec L, Kvien T.

Arthritis Res Ther. 2012 May 30;14(3):R129. doi: 10.1186/ar3859.

10.

Onset of action of etanercept in rheumatoid arthritis based on patient-reported outcomes.

Dougados M, Ripert M, Hilliquin P, Brocq O, Brault Y, Logeart I.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2):266-8. Epub 2012 Apr 13.

PMID:
22325048
11.

Metrologic properties of ultrasound versus clinical evaluation of synovitis in rheumatoid arthritis: results of a multicenter, randomized study.

Mandl P, Balint PV, Brault Y, Backhaus M, D'Agostino MA, Grassi W, van der Heijde D, de Miguel E, Wakefield RJ, Logeart I, Dougados M.

Arthritis Rheum. 2012 Apr;64(4):1272-82. doi: 10.1002/art.33491. Epub 2011 Nov 30.

12.

The influence of the definition of patient global assessment in assessment of disease activity according to the Disease Activity Score (DAS28) in rheumatoid arthritis.

Dougados M, Ripert M, Hilliquin P, Fardellone P, Brocq O, Brault Y, Logeart I.

J Rheumatol. 2011 Nov;38(11):2326-8. doi: 10.3899/jrheum.110487. Epub 2011 Oct 1.

PMID:
21965642
13.

Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis.

Paul C, Stalder JF, Thaçi D, Vincendon P, Brault Y, Kielar D, Tebbs V.

J Eur Acad Dermatol Venereol. 2012 Apr;26(4):448-55. doi: 10.1111/j.1468-3083.2011.04093.x. Epub 2011 May 10.

PMID:
21557778
14.

Similar lipid profile but improved long-term outcomes with sirolimus after cyclosporine withdrawal compared to sirolimus with continuous cyclosporine.

Morales JM, Hartmann A, Walker R, Arns W, Senatorski G, Grinyó JM, Shoker A, Wilczek H, Jamieson NV, Lelong M, Brault Y, Burke JT, Scarola JA; Rapamune Maintenance Regimen Study Group.

Transplant Proc. 2009 Jul-Aug;41(6):2339-44. doi: 10.1016/j.transproceed.2009.05.009.

PMID:
19715914
15.

Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients.

Rovira J, Marcelo Arellano E, Burke JT, Brault Y, Moya-Rull D, Bañón-Maneus E, Ramírez-Bajo MJ, Gutiérrez-Dalmau A, Revuelta I, Quintana LF, Campistol JM, Diekmann F.

Transpl Int. 2008 Oct;21(10):992-8. doi: 10.1111/j.1432-2277.2008.00710.x. Epub 2008 Jul 24.

16.

Accuracy and variability of equations to estimate glomerular filtration rates in renal transplant patients receiving sirolimus and/or calcineurin inhibitor immunosuppression.

Burke JT, Brault Y, Kahan BD, Hricik DE, Grinyó JM, Chapman JR, Polinsky M, Neylan JF.

Transpl Int. 2008 May;21(5):434-40. doi: 10.1111/j.1432-2277.2007.00624.x. Epub 2008 Jan 9.

17.

Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function.

Friend P, Russ G, Oberbauer R, Murgia MG, Tufveson G, Chapman J, Blancho G, Mota A, Grandaliano G, Campistol JM, Brault Y, Burke JT; Rapamune Maintenance Regimen (RMR) Study Group.

Transpl Int. 2007 Sep;20(9):754-60. Epub 2007 Jun 12.

18.

Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: a multivariate analysis of results at five years.

Legendre C, Brault Y, Morales JM, Oberbauer R, Altieri P, Riad H, Mahony J, Messina M, Pussell B, Martínez JG, Lelong M, Burke JT, Neylan JF; Rapamune Maintenance Regimen Study Group.

Clin Transplant. 2007 May-Jun;21(3):330-6.

PMID:
17488381
19.

Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation.

Campistol JM, Eris J, Oberbauer R, Friend P, Hutchison B, Morales JM, Claesson K, Stallone G, Russ G, Rostaing L, Kreis H, Burke JT, Brault Y, Scarola JA, Neylan JF.

J Am Soc Nephrol. 2006 Feb;17(2):581-9.

20.

Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.

Morales JM, Campistol JM, Kreis H, Mourad G, Eris J, Schena FP, Grinyo JM, Nanni G, Andres A, Castaing N, Brault Y, Burke JT.

Transplant Proc. 2005 Mar;37(2):693-6.

PMID:
15848504
21.

Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation.

Oberbauer R, Segoloni G, Campistol JM, Kreis H, Mota A, Lawen J, Russ G, Grinyó JM, Stallone G, Hartmann A, Pinto JR, Chapman J, Burke JT, Brault Y, Neylan JF; Rapamune Maintenance Regimen Study Group.

Transpl Int. 2005 Jan;18(1):22-8. Erratum in: Transpl Int. 2005 Mar;18(3):369.

22.

Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years.

Mota A, Arias M, Taskinen EI, Paavonen T, Brault Y, Legendre C, Claesson K, Castagneto M, Campistol JM, Hutchison B, Burke JT, Yilmaz S, Häyry P, Neylan JF; Rapamune Maintenance Regimen Trial.

Am J Transplant. 2004 Jun;4(6):953-61.

23.

Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.

Kreis H, Oberbauer R, Campistol JM, Mathew T, Daloze P, Schena FP, Burke JT, Brault Y, Gioud-Paquet M, Scarola JA, Neylan JF; Rapamune Maintenance Regimen Trial.

J Am Soc Nephrol. 2004 Mar;15(3):809-17.

24.

Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.

Meoni P, Salinas E, Brault Y, Hackett D.

J Clin Psychiatry. 2001 Nov;62(11):888-93.

PMID:
11775049
25.

Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group.

Chaine G, Hullo A, Sahel J, Soubrane G, Espinasse-Berrod MA, Schutz D, Bourguignon C, Harpey C, Brault Y, Coste M, Moccatti D, Bourgeois H.

Br J Ophthalmol. 1998 Sep;82(9):996-1002.

26.

[Evaluation of trough/peak ratio of indapamide 1.5 mg sustained-release form assessed by ambulatory blood pressure monitoring].

Mallion JM, Asmar R, Ambrosioni E, MacMahon M, Coupez JM, de Cordoüe A, Barrandon S, Brault Y, Guez D, Safar M.

Arch Mal Coeur Vaiss. 1996 Sep;89 Spec No 4:27-38. French.

PMID:
8952811
27.

Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide.

Curry CL, Robinson H, Brown R, Olivan J, Sami M, Honos G, Ruddy TD, Balazovjech I, Touzek F, Galinier F, Mariani M, de Cordoüe A, Barrandon S, Brault Y, Guez D.

Am J Hypertens. 1996 Aug;9(8):828-32.

PMID:
8862231
29.

[Therapeutic benefit of a low dose of indapamide: results of a double-blind against placebo European controlled study].

Asmar R, Guez D, Malbezin M, Brault Y, de Cordoue A, Barrandon S, Bruxelles MC, Chastang C.

Arch Mal Coeur Vaiss. 1995 Aug;88(8):1083-7. French.

PMID:
8572850
30.

Clinical and electrophysiological study of the peripheral nervous system in the elderly.

Bouche P, Cattelin F, Saint-Jean O, Léger JM, Queslati S, Guez D, Moulonguet A, Brault Y, Aquino JP, Simunek P.

J Neurol. 1993 May;240(5):263-8.

PMID:
8326328
31.

Effect of a dopaminergic agonist, piribedil (Trivastal 50 mg LP), on visual and spatial integration in elderly subjects.

Corbe C, Arnaud F, Brault Y, Janiak-Bolzinger C.

J Neurol. 1992;239 Suppl 1:S22-7.

PMID:
1634908
32.

A hybrid device for measurement of left ventricular heat production.

Jarry G, Bui-Mong-Hung, Maarek JM, Brault Y, Lautier A, Laurent D.

J Biomed Eng. 1982 Jul;4(3):227-32.

PMID:
7120979
33.

Online calculation of lung volumes by digital computer from a plethysmorgraphic measurement of ventilatory flow.

Lorino H, Laurent D, Harf A, Brault Y, Lorino AM, Atlan G.

Med Biol Eng Comput. 1980 May;18(3):291-8. No abstract available.

PMID:
7421310
34.

Computer determination of thoracic gas volume using plethysmographic "thoracic flow".

Lorino H, Harf A, Atlan G, Brault Y, Lorino AM, Laurent D.

J Appl Physiol Respir Environ Exerc Physiol. 1980 May;48(5):911-6.

PMID:
7005200
35.

On-line calculation of pulmonary mechanics by digital computer.

Lorino H, Brault Y, Harf A, Atlan G, Lorino AM, Laurent D.

Methods Inf Med. 1978 Oct;17(4):261-72. No abstract available.

PMID:
732589
36.

[Neuro-physiological basis of physical therapy of hemiplegic patients].

Brault Y.

Union Med Can. 1976 May;105(5):751-6. French. No abstract available.

PMID:
1084612

Supplemental Content

Loading ...
Support Center